235 related articles for article (PubMed ID: 15515615)
1. Minimally invasive esophagectomy.
Gilbert S; Luketich JD
Adv Surg; 2004; 38():67-83. PubMed ID: 15515615
[No Abstract] [Full Text] [Related]
2. The sweet approach is still worthwhile in modern esophagectomy.
Ma J; Zhan C; Wang L; Jiang W; Zhang Y; Shi Y; Wang Q
Ann Thorac Surg; 2014 May; 97(5):1728-33. PubMed ID: 24650587
[TBL] [Abstract][Full Text] [Related]
3. Intramucosal esophageal cancer and high-grade dysplasia: which treatment frame the debate.
Oelschlager BK
J Gastrointest Surg; 2009 Jul; 13(7):1169-71. PubMed ID: 19322615
[No Abstract] [Full Text] [Related]
4. Robotic esophagectomy: is it an advance and what is the future?
Watson TJ
Ann Thorac Surg; 2008 Feb; 85(2):S757-9. PubMed ID: 18222211
[No Abstract] [Full Text] [Related]
5. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
[TBL] [Abstract][Full Text] [Related]
6. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
[No Abstract] [Full Text] [Related]
7. [Selective use of transhiatal esophagectomy for esophageal cancer].
Haeder L; Jähne J
Chirurg; 2012 Jul; 83(7):669. PubMed ID: 22782176
[No Abstract] [Full Text] [Related]
8. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
9. [MINIMALLY INVASIVE ESOPHAGECTOMY].
Levchenko EV; Khandogin NV; Karachun AM; Shcherbakov AM; Dvoretsky SY; Radzhabova ZA; Komarov IV; Ivashikin YM; Armasheva MV; Barchuk AS; Gorokhov LV
Vopr Onkol; 2015; 61(3):376-80. PubMed ID: 26242148
[TBL] [Abstract][Full Text] [Related]
10. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
11. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Management of Early Upper Gastrointestinal Bleeding After Minimally Invasive Ivor-Lewis Esophagectomy.
Zhang RQ; Kang NN; Che Y; Xia WL; Yu ZC; Pan HG; Ge W; Chen AG; Wan J
Ann Thorac Surg; 2016 Apr; 101(4):1581-4. PubMed ID: 27000582
[TBL] [Abstract][Full Text] [Related]
14. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive esophagectomy.
Dziodzio T; Kröll D; Denecke C; Öllinger R; Pratschke J; Biebl M
Multimed Man Cardiothorac Surg; 2021 Apr; 2021():. PubMed ID: 33914420
[TBL] [Abstract][Full Text] [Related]
16. Resection for esophageal cancer: strategies for optimal management.
Pennathur A; Luketich JD
Ann Thorac Surg; 2008 Feb; 85(2):S751-6. PubMed ID: 18222210
[TBL] [Abstract][Full Text] [Related]
17. SSAT controversies intramucosal esophageal cancer and high-grade dysplasia: which treatment? Surgical therapy: improved outcomes and piece of mind.
Peters JH
J Gastrointest Surg; 2009 Jul; 13(7):1179-81. PubMed ID: 19294473
[No Abstract] [Full Text] [Related]
18. Short-term outcomes of minimally invasive Ivor-Lewis esophagectomy for esophageal cancer.
Xie MR; Liu CQ; Guo MF; Mei XY; Sun XH; Xu MQ
Ann Thorac Surg; 2014 May; 97(5):1721-7. PubMed ID: 24657031
[TBL] [Abstract][Full Text] [Related]
19. The dilemma of T1 esophageal adenocarcinoma.
Molena D; DeMeester SR
J Thorac Cardiovasc Surg; 2017 May; 153(5):1206-1207. PubMed ID: 28314532
[No Abstract] [Full Text] [Related]
20. [The road to modern esophageal surgery - from maximally invasive to minimally invasive].
von Holzen U
Praxis (Bern 1994); 2014 Aug; 103(16):955-60. PubMed ID: 25097164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
